Chaetocin antileukemia activity against chronic myelogenous leukemia cells is potentiated by bone marrow stromal factors and overcomes innate imatinib resistance

Chronic myelogenous leukemia (CML) is maintained by a minor population of leukemic stem cells (LSCs) that exhibit innate resistance to tyrosine kinase inhibitors (TKIs) targeting BCR-ABL. Innate resistance can be induced by secreted bone marrow stromal cytokines and growth factors (BMSFs) that prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Truitt, L, Hutchinson, C, DeCoteau, J F, Geyer, C R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216903/
https://www.ncbi.nlm.nih.gov/pubmed/25329721
http://dx.doi.org/10.1038/oncsis.2014.37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216903/
https://www.ncbi.nlm.nih.gov/pubmed/25329721
http://dx.doi.org/10.1038/oncsis.2014.37

Ejemplares similares